SA Transcripts 162.58K Followers

Novartis AG (NVS) Discusses REMODEL Trial Results for Remibrutinib in Relapsing Multiple Sclerosis October 23, 2026 6:30 PM EDT

Company Participants

Inish O'Doherty

Nazem Atassi

Victor Bulto - President of US

Conference Call Participants

Heinz Wiendl

Michael Leuchten - Jefferies LLC, Research Division

Alek Ebbeling - UBS Investment Bank, Research Division

Thibault Boutherin - Morgan Stanley, Research Division

James Quigley - Goldman Sachs Group, Inc., Research Division

Richard Vosser - JPMorgan Chase & Co, Research Division

Simon Baker - Rothschild & Co Redburn, Research Division

Steve Scala - TD Cowen, Research Division

Presentation

Operator

Good morning and good afternoon, and welcome to Novartis conference call and live webcast. [Operator Instructions] The conference is being recorded.…